Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-140056
Filing Date
2026-04-02
Accepted
2026-04-02 16:05:06
Documents
1
Period of Report
2026-04-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5558
  Complete submission text file 0001193125-26-140056.txt   7130
Mailing Address C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address
SMITH IAN F (Reporting) CIK: 0001197032 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38360 | Film No.: 26833279

Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Issuer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)